Holen Sie sich die Stockscreener-App
492.27
0.25%
1.445
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt UTHR?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$490.83
Offen:
$492.13
24-Stunden-Volumen:
27,883
Relative Volume:
0.06
Marktkapitalisierung:
$21.19B
Einnahmen:
$3.08B
Nettoeinkommen (Verlust:
$1.24B
KGV:
19.22
EPS:
25.6108
Netto-Cashflow:
$1.07B
1W Leistung:
-0.94%
1M Leistung:
+3.30%
6M Leistung:
+63.71%
1J Leistung:
+34.22%
1-Tages-Spanne:
$485.83
$493.27
1-Wochen-Bereich:
$479.59
$512.74
52-Wochen-Spanne:
$266.98
$519.99
United Therapeutics Corp Stock (UTHR) Company Profile
Firmenname
United Therapeutics Corp
Sektor
Telefon
(301) 608-9292
Adresse
1000 SPRING ST, SILVER SPRING, MD
Vergleichen Sie UTHR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
492.25 | 21.13B | 3.08B | 1.24B | 1.07B | 25.61 |
|
ZTS
Zoetis Inc
|
126.26 | 55.90B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.33 | 51.72B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.91 | 44.71B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.03 | 37.30B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
50.10 | 20.48B | 0 | -5.87M | -767.30K | -0.45 |
United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Underweight |
| 2025-09-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-06-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-04-21 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-07-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | Hochstufung | Goldman | Sell → Neutral |
| 2024-02-05 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-06 | Eingeleitet | UBS | Buy |
| 2022-12-05 | Eingeleitet | Goldman | Sell |
| 2022-10-11 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-09-20 | Bestätigt | BofA Securities | Underperform |
| 2022-09-19 | Fortgesetzt | Wedbush | Outperform |
| 2022-02-11 | Eingeleitet | BTIG Research | Neutral |
| 2021-07-14 | Hochstufung | Argus | Hold → Buy |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-02-01 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | Fortgesetzt | JP Morgan | Overweight |
| 2020-06-25 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-03-10 | Hochstufung | Jefferies | Hold → Buy |
| 2020-02-27 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-01-31 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-12-03 | Eingeleitet | BofA/Merrill | Underperform |
| 2019-08-01 | Hochstufung | Jefferies | Underperform → Hold |
| 2019-08-01 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-09 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | Hochstufung | Standpoint Research | Hold → Buy |
| 2018-08-08 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | Bestätigt | Barclays | Underweight |
| 2018-01-18 | Fortgesetzt | Credit Suisse | Underperform |
| 2017-12-27 | Bestätigt | Wedbush | Outperform |
| 2017-04-27 | Bestätigt | Wedbush | Outperform |
| 2017-03-30 | Eingeleitet | UBS | Sell |
| 2017-03-16 | Eingeleitet | Credit Suisse | Underperform |
Alle ansehen
United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten
How United Therapeutics Corporation (UTH) stock expands through international marketsTreasury Yields & Verified Swing Trading Watchlists - ulpravda.ru
Is United Therapeutics Corporation stock a good choice for value investorsJuly 2025 Recap & AI Enhanced Execution Alerts - ulpravda.ru
MannKind Provides Business Updates and 2026 Growth Drivers - Benzinga
Director Jan Malcolm Sells Shares of United Therapeutics Corp - GuruFocus
United Therapeutics (UTHR): UBS Raises Price Target, Maintains B - GuruFocus
United Therapeutics (NASDAQ:UTHR) Director Christopher Causey Sells 1,000 Shares - MarketBeat
United Therapeutics Corporation $UTHR Shares Bought by Merit Financial Group LLC - MarketBeat
Allspring Global Investments Holdings LLC Acquires 4,944 Shares of United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (NASDAQ:UTHR) EVP Paul Mahon Sells 8,300 Shares - MarketBeat
United Therapeutics Corporation $UTHR Position Increased by Cwm LLC - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Sells 137,900 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock - Yahoo Finance
United Therapeutics (NASDAQ:UTHR) COO Michael Benkowitz Sells 22,500 Shares - MarketBeat
Insider Selling: United Therapeutics (NASDAQ:UTHR) COO Sells 22,500 Shares of Stock - MarketBeat
United Therapeutics EVP & General Counsel Sells 11,000 Shares - TradingView — Track All Markets
Death Cross: Can United Therapeutics Corporation stock sustain market leadershipTrend Reversal & AI Based Buy/Sell Signal Reports - moha.gov.vn
Pacer Advisors Inc. Decreases Position in United Therapeutics Corporation $UTHR - MarketBeat
S&P 500 Futures Flat In Premarket Trading; United Therapeutics, Intel Lag - 富途牛牛
S&P 500 Futures Flat in Premarket Trading; United Therapeutics, Intel Lag - Barron's
United Therapeutics (NASDAQ:UTHR) Reaches New 1-Year HighHere's What Happened - MarketBeat
United Therapeutics (NASDAQ:UTHR) Nasdaq Index Targeted Biotech - Kalkine Media
Insider Sell: Jan Malcolm Sells Shares of United Therapeutics Co - GuruFocus
Jan Malcolm Sells 50 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
United Therapeutics (NASDAQ:UTHR) Director Louis Sullivan Sells 5,950 Shares - MarketBeat
United Therapeutics Director Malcolm Jan Sells Shares - TradingView — Track All Markets
Voya Investment Management LLC Lowers Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Wedge Capital Management L L P NC Reduces Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (UTHR): Revisiting Valuation After Xenotransplantation Progress and Strong Financial Performance - simplywall.st
Will United Therapeutics Corporation (UTH) stock see valuation expansionJuly 2025 Earnings & Safe Capital Allocation Plans - Улправда
VIX Spike: Will United Therapeutics Corporation (UTH) stock see valuation expansionQuarterly Investment Review & Growth-Oriented Investment Plans - Улправда
Chmn Rothblatt Files To Sell 2,000 Of United Therapeutics Corp [UTHR] - TradingView — Track All Markets
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 2,000 Shares - MarketBeat
United Therapeutics Executives Engage in Stock Transactions - TradingView — Track All Markets
Published on: 2025-12-19 23:14:09 - Улправда
United Therapeutics stock hits all-time high at 514.05 USD - Investing.com
United Therapeutics stock hits all-time high at 514.05 USD By Investing.com - Investing.com Canada
How resilient is United Therapeutics Corporation stock in market downturnsJuly 2025 Gainers & Free Community Consensus Stock Picks - Улправда
Why United Therapeutics Corporation stock could see breakout soonJuly 2025 Levels & Daily Chart Pattern Signal Reports - DonanımHaber
Osaic Holdings Inc. Raises Stake in United Therapeutics Corporation $UTHR - MarketBeat
Will United Therapeutics Corporation (UTH) stock beat revenue estimatesJuly 2025 Action & Free High Accuracy Swing Entry Alerts - Улправда
Chmn Rothblatt Files To Sell 4,000 Of United Therapeutics Corp [UTHR] - TradingView — Track All Markets
Will Insider Stock Sales Amid EXPAND Xenotransplantation Progress Change United Therapeutics' (UTHR) Narrative? - simplywall.st
James Edgemond Sells 3,517 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
Martine Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
United Therapeutics (NASDAQ:UTHR) Director Sells $495,950.00 in Stock - MarketBeat
UNITED THERAPEUTICS Director Sells 1,000 Shares - TradingView — Track All Markets
[Form 4] UNITED THERAPEUTICS Corp Insider Trading Activity - Stock Titan
Dir Patusky Files To Sell 1,000 Of United Therapeutics Corp [UTHR] - TradingView — Track All Markets
Texas Permanent School Fund Corp Increases Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Thrivent Financial for Lutherans Has $53.30 Million Holdings in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corporation (NASDAQ:UTHR) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Finanzdaten der United Therapeutics Corp-Aktie (UTHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
United Therapeutics Corp-Aktie (UTHR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BENKOWITZ MICHAEL | PRESIDENT AND COO |
Jan 05 '26 |
Sale |
487.38 |
14,625 |
7,127,877 |
0 |
| BENKOWITZ MICHAEL | PRESIDENT AND COO |
Jan 05 '26 |
Option Exercise |
146.03 |
7,875 |
1,149,986 |
7,875 |
| BENKOWITZ MICHAEL | PRESIDENT AND COO |
Jan 05 '26 |
Sale |
487.38 |
7,875 |
3,838,085 |
0 |
| CAUSEY CHRISTOPHER | Director |
Jan 06 '26 |
Option Exercise |
119.76 |
1,000 |
119,760 |
5,190 |
| CAUSEY CHRISTOPHER | Director |
Jan 06 '26 |
Sale |
510.00 |
1,000 |
510,000 |
4,190 |
| MALCOLM JAN | Director |
Jan 05 '26 |
Sale |
495.01 |
50 |
24,750 |
370 |
5.65%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):